tiprankstipranks
Holding GB:3LAZ?
Track your performance easily

GB:3LAZ Technical Analysis

Summary of all the Indicators

Summary
Sell
5Bullish
5Neutral
12Bearish
Oscillators
Sell
2Bullish
5Neutral
3Bearish
Moving Averages
Strong Sell
3Bullish
0Neutral
9Bearish
GraniteShares 3x Long Astrazeneca Daily ETP’s (3LAZ) Moving Averages Convergence Divergence (MACD) indicator is -402.43, suggesting GraniteShares 3x Long Astrazeneca Daily ETP is a Sell.
GraniteShares 3x Long Astrazeneca Daily ETP’s (3LAZ) 20-Day exponential moving average is 2542.02, making it a Sell.
GraniteShares 3x Long Astrazeneca Daily ETP’s (3LAZ) 50-Day exponential moving average is 3182.29, making it a Sell.

GraniteShares 3x Long Astrazeneca Daily ETP (3LAZ) Pivot Points

Nov 23, 2024, 12:11 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1,974.00
2,037.75
2,085.00
2,148.75
2,196.00
2,259.75
2,307.00
Fibonacci
2,037.75
2,080.15
2,106.35
2,148.75
2,191.15
2,217.35
2,259.75

GraniteShares 3x Long Astrazeneca Daily ETP (3LAZ) Moving Averages

Nov 23, 2024, 12:11 AM
Period
Simple
Exponential
MA5
2,127.20Buy
2,157.05Buy
MA10
2,159.30Buy
2,246.71Sell
MA20
2,590.44Sell
2,542.02Sell
MA50
3,284.33Sell
3,182.29Sell
MA100
3,975.77Sell
3,605.54Sell
MA200
3,832.86Sell
3,540.73Sell
GraniteShares 3x Long Astrazeneca Daily ETP’s (3LAZ) 10-Day exponential moving average is 2246.71, making it a Sell.
GraniteShares 3x Long Astrazeneca Daily ETP’s (3LAZ) 100-Day exponential moving average is 3605.54, making it a Sell.
GraniteShares 3x Long Astrazeneca Daily ETP’s (3LAZ) 50-day simple moving average is 3284.32, creating a Sell signal.
GraniteShares 3x Long Astrazeneca Daily ETP’s (3LAZ) 100-day simple moving average is 3975.77, creating a Sell signal.
GraniteShares 3x Long Astrazeneca Daily ETP’s (3LAZ) 200-day simple moving average is 3832.86, creating a Sell signal.

GraniteShares 3x Long Astrazeneca Daily ETP (3LAZ) Technical Analysis

Nov 23, 2024, 12:11 AM
Name
Value
Action
RSI (14)
30.87
Neutral
STOCH (9,6)
42.41
Neutral
STOCHRSI (14)
16.93
Buy
MACD (12,26)
-402.43
Sell
ADX (14)
37.55
Neutral
Williams %R
-81.72
Buy
CCI (14)
-55.02
Neutral
ATR (14)
202.36
-
Ultimate Oscillator
43.02
Neutral
ROC
-27.24
Sell
GraniteShares 3x Long Astrazeneca Daily ETP’s (3LAZ) Relative Strength Index (RSI) is 30.87, creating a Neutral signal.
GraniteShares 3x Long Astrazeneca Daily ETP’s (3LAZ) Trend Strength Indicator (ADX) is 37.55, creating a Neutral signal.
GraniteShares 3x Long Astrazeneca Daily ETP’s (3LAZ) Commodity Channel Index (CCI) is -55.02, creating a Neutral signal.
GraniteShares 3x Long Astrazeneca Daily ETP’s (3LAZ) Price Rate of Change (ROC) is -27.24, creating a Sell signal.

FAQ

Is 3LAZ a Buy, Hold, or Sell?
Based on 3LAZ’s technical indicators, 3LAZ is a Sell.
    What is 3LAZ’s RSI (14)?
    3LAZ’s RSI (14) is 30.87, which suggests 3LAZ is a Neutral.
      What is 3LAZ’s MACD?
      3LAZ’s MACD is -402.43, which suggests 3LAZ is a Sell.
        What is 3LAZ’s 5-day moving average?
        3LAZ’s 5-day moving average is 2127.20, which suggests 3LAZ is a Buy.
          What is 3LAZ’s 20-day moving average?
          3LAZ 20-day moving average is 2590.44, which suggests 3LAZ is a Sell.
            What is 3LAZ’s 50-day moving average?
            3LAZ’s 50-day moving average is 3284.32, which suggests 3LAZ is a Sell.
              What is 3LAZ’s 200-day moving average?
              3LAZ’s 200-day moving average is 3832.86, which suggests 3LAZ is a Sell.
                What is 3LAZ’s Williams % R (14)?
                3LAZ’s Williams % R (14) is -81.72, which suggests 3LAZ is a Buy.
                  What is 3LAZ’s CCI (14)?
                  3LAZ’s CCI (14) is -55.02, which suggests 3LAZ is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis